Bayer AG Drug For Further Processing
NDC Database

Bayer AG Drug For Further Processing

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 17
  • Latest Marketing Date 2026-06-12
  • Data Source FDA
  • First Marketing Date 1982-12-29
All
40
View
Bulk Ingredient
23
View
Drug for Further Processing
17
View
Company Overview

Company

Bayer AG Drug For Further Processing

Country

Germany

Website

Visit Website

Email

pharmachemicals@bayer.com

Social Profiles

Company Snapshot

Bayer AG Drug For Further Processing

Mullerstr. 178, 13353 Berlin

Germany

pharma.bayer.com/ pharmachemicals@bayer.com View on Map
NDC Records ( 17 records )
2018
01 Sep
Drug for Further Processing NDC: 12527-0171

Nonproprietary Name

regorafenib

Dosage Form

TABLET, FILM COATED

Strength

40 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0171

Substance

REGORAFENIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2018
01 Sep
Drug for Further Processing NDC: 12527-0250

Nonproprietary Name

riociguat

Dosage Form

TABLET, FILM COATED

Strength

0.5 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0250

Substance

RIOCIGUAT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2018
01 Sep
Drug for Further Processing NDC: 12527-0251

Nonproprietary Name

riociguat

Dosage Form

TABLET, FILM COATED

Strength

1 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0251

Substance

RIOCIGUAT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2018
01 Sep
Drug for Further Processing NDC: 12527-0252

Nonproprietary Name

riociguat

Dosage Form

TABLET, FILM COATED

Strength

1.5 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0252

Substance

RIOCIGUAT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2018
01 Sep
Drug for Further Processing NDC: 12527-0253

Nonproprietary Name

riociguat

Dosage Form

TABLET, FILM COATED

Strength

2 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0253

Substance

RIOCIGUAT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2018
01 Sep
Drug for Further Processing NDC: 12527-0254

Nonproprietary Name

riociguat

Dosage Form

TABLET, FILM COATED

Strength

2.5 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0254

Substance

RIOCIGUAT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2025
19 Nov
Drug for Further Processing NDC: 12527-0397

Nonproprietary Name

Sevabertinib

Dosage Form

TABLET, COATED

Strength

10 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0397

Substance

SEVABERTINIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-11-19

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2021
09 Jul
Drug for Further Processing NDC: 12527-0541

Nonproprietary Name

finerenone

Dosage Form

TABLET, FILM COATED

Strength

20 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0541

Substance

FINERENONE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-07-09

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2021
09 Jul
Drug for Further Processing NDC: 12527-0640

Nonproprietary Name

finerenone

Dosage Form

TABLET, FILM COATED

Strength

10 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-0640

Substance

FINERENONE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-07-09

End Marketing Date

-

Listing Record Certified Through

2027-12-31

1982
29 Dec
Drug for Further Processing NDC: 12527-2521

Nonproprietary Name

praziquantel

Dosage Form

TABLET, FILM COATED

Strength

600 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-2521

Substance

PRAZIQUANTEL

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1982-12-29

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2021
04 Jan
Drug for Further Processing NDC: 12527-5028

Nonproprietary Name

vericiguat

Dosage Form

TABLET, FILM COATED

Strength

2.5 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-5028

Substance

VERICIGUAT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-01-04

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
04 Jan
Drug for Further Processing NDC: 12527-5029

Nonproprietary Name

vericiguat

Dosage Form

TABLET, FILM COATED

Strength

5 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-5029

Substance

VERICIGUAT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-01-04

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
04 Jan
Drug for Further Processing NDC: 12527-5030

Nonproprietary Name

vericiguat

Dosage Form

TABLET, FILM COATED

Strength

10 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-5030

Substance

VERICIGUAT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-01-04

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
01 Sep
Drug for Further Processing NDC: 12527-8488

Nonproprietary Name

sorafenib

Dosage Form

TABLET, FILM COATED

Strength

200 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-8488

Substance

SORAFENIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

1997
26 Sep
Drug for Further Processing NDC: 12527-8512

Nonproprietary Name

ciprofloxacin hydrochloride

Dosage Form

TABLET, FILM COATED

Strength

250 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-8512

Substance

CIPROFLOXACIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1997-09-26

End Marketing Date

-

Listing Record Certified Through

2027-12-31

1997
26 Aug
Drug for Further Processing NDC: 12527-8513

Nonproprietary Name

ciprofloxacin hydrochloride

Dosage Form

TABLET, FILM COATED

Strength

500 mg/1

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12527-8513

Substance

CIPROFLOXACIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1997-08-26

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2026
12 Jun
Drug for Further Processing NDC: 12866-3230

Nonproprietary Name

Gadoquatrane

Dosage Form

INJECTION

Strength

257.9 mg/mL

Labeler

Bayer AG

Marketing Category

DRUG FOR FURTHER PROCESSING

12866-3230

Substance

GADOQUATRANE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2026-06-12

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    43 View
  • EDQM CEP
    34 View
  • KDMF
    0 View
  • Japan DMF
    4 View
  • Eudra GMP
    0 View
  • NDC Database
    40 View
  • FDA Approved Drugs Database
    277 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
17 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

12527-0171

Nonproprietary Name

regorafenib

Labeler

Bayer AG

Dosage Form

TABLET, FILM COATED

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit